Inmune Bio, Inc. Annual Operating Margin in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Inmune Bio, Inc. quarterly/annual Operating Margin history and growth rate from 2020 to 2023.
  • Inmune Bio, Inc. Operating Margin for the quarter ending March 31, 2024 was -26.2K %, a 152% decline year-over-year.
  • Inmune Bio, Inc. annual Operating Margin for 2023 was -19.2K %, a 177% decline from 2022.
  • Inmune Bio, Inc. annual Operating Margin for 2022 was -6.94K %, a 56.9% increase from 2021.
  • Inmune Bio, Inc. annual Operating Margin for 2021 was -16.1K %, a 85.5% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -19.2K -12.2K -177% Jan 1, 2023 Dec 31, 2023
2022 -6.94K +9.17K +56.9% Jan 1, 2022 Dec 31, 2022
2021 -16.1K +95.1K +85.5% Jan 1, 2021 Dec 31, 2021
2020 -111K Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.